TABLE 4Studies included in previous systematic reviews with eligibility for inclusion in current review

StudyIncluded in previous systematic reviews?Include in current review?Comments
Kreymann et al. (2007)10Laupland et al. (2007)11Turgeon et al. (2007)12Norrby-Tegland et al. (2006)13Pildal and Gøtzsche (2004)14Alejandria et al. (2002)9Alejandria et al.(2010)15 [update]
Rodriguez et al. (2005)42XXXXXYes
Hentrich et al. (2006)43XXXXYes
Karatzas et al. (2002)44XXXXXYes
Tugrul et al. (2002)45XXXXXXYes
Behre et al. (1995)46XXXXYes
Schedel et al. (1991)47XXXXXXXYes
Wesoly et al. (1990)48XXXXXXYesIncluded after consultation with clinicians (MSH and MS)
Vogel et al. (1988)38XXNoFrom book chapter – reported data same as Spannbrucker et al.49
Spannbrucker et al. (1987)49XYes
Just et al. (1986)40XXXXXNoExcluded after consultation with clinicians (MSH and MS)
Dominioni et al. (1996)50XXXXXYes
Burns et al. (1991)51XXXXYesIncluded after consultation with clinicians (MSH and MS)
Dominioni et al. (1991)39XXNoReported data interim analysis for Dominioni et al.50
De Simone et al. (1988)52XXXXXXYes
Werden et al. (2007)53XXXXXYes
Grundmann and Hornung (1988)54XXXXXXYes
Yakut et al. (1998)55XXXXXYes
Darenberg et al. (2003)56XXXXXYes
Jesdinsky et al. (1987)41XNoIntervention mixture of commercially available IgG with unspecified, locally produced IgM preparation, not generally available. Trial terminated early because of the lack of supply of intervention. Population not relevanta
Lindquist et al. (1981)57XXXYesIncluded after consultation with clinicians (MSH and MS)
Masaoka et al. (2000)58XXYes

X, study included.

a

Reasons for exclusion taken from Kreymann et al.10

From: 3, Clinical effectiveness of intravenous immunoglobulin for severe sepsis and septic shock

Cover of An Evaluation of the Feasibility, Cost and Value of Information of a Multicentre Randomised Controlled Trial of Intravenous Immunoglobulin for Sepsis (Severe Sepsis and Septic Shock): Incorporating a Systematic Review, Meta-Analysis and Value of Information Analysis
An Evaluation of the Feasibility, Cost and Value of Information of a Multicentre Randomised Controlled Trial of Intravenous Immunoglobulin for Sepsis (Severe Sepsis and Septic Shock): Incorporating a Systematic Review, Meta-Analysis and Value of Information Analysis.
Health Technology Assessment, No. 16.7.
Soares MO, Welton NJ, Harrison DA, et al.
Southampton (UK): NIHR Journals Library; 2012 Feb.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.